Viewing Study NCT01827267


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-02-18 @ 9:46 AM
Study NCT ID: NCT01827267
Status: COMPLETED
Last Update Posted: 2018-07-03
First Post: 2013-04-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer
Sponsor: Puma Biotechnology, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-mutant Non-Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lung cancer View
None Puma View
None neratinib View
None HKI-272 View
None PB-272 View
None Nerlynx View